EPHA2 and glioblastoma: Other cell surface markers such as EGFRvIII and ephrin-A2 (EphA2) have been found to be efficacious targets for CAR T cells in xenograft models of GBM (Chow et al., 2013; Sampson et al., 2014; Johnson et al., 2015).